Xias Bio is a biotech startup producing soluble and active recombinant proteins for formulators, featuring improved gel and film formations.
Xias Bio has raised $4.8M in total funding. The most recent round was Seed. The last funding was announced in May 2024.
Xias Bio's investors include SOSV, IndieBio, Good Startup, BoxOne Ventures, Happiness Capital.
Xias Bio is headquartered in Glasgow, United Kingdom.
Xias Bio is a biotech startup producing soluble and active recombinant proteins for formulators, featuring improved gel and film formations.
Xias Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xias Bio — Funding & Investors." VCBacked, May 1, 2024, https://www.vcbacked.co/company/xias-bio. Accessed September 14, 2026.
VCBacked. (2024). Xias Bio — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/xias-bio
{{cite web |title=Xias Bio — Funding & Investors |url=https://www.vcbacked.co/company/xias-bio |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated